The Relationship Between Cumulative Unfair Treatment and Intima Media Thickness and Adventitial Diameter: The Moderating Role of Race in The Study of Women’s Health Across the Nation by Peterson, Laurel M. et al.
Bryn Mawr College
Scholarship, Research, and Creative Work at Bryn Mawr
College
Psychology Faculty Research and Scholarship Psychology
2016
The Relationship Between Cumulative Unfair
Treatment and Intima Media Thickness and
Adventitial Diameter: The Moderating Role of
Race in The Study of Women’s Health Across the
Nation
Laurel M. Peterson
Bryn Mawr College, lmpeterson@brynmawr.edu
Karen A. Matthews
Carol A. Derby
Joyce T. Bromberger
Rebecca C. Thurston
Let us know how access to this document benefits you.
Follow this and additional works at: http://repository.brynmawr.edu/psych_pubs
Part of the Psychology Commons
This paper is posted at Scholarship, Research, and Creative Work at Bryn Mawr College. http://repository.brynmawr.edu/psych_pubs/46
For more information, please contact repository@brynmawr.edu.
Custom Citation
Peterson, L., Matthews, K. A., Derby, C. A., Bromberger, J. T., and Thurston, R. C. 2016. "The Relationship Between Cumulative
Unfair Treatment and Intima Media Thickness and Adventitial Diameter: The Moderating Role of Race in The Study of Women’s
Health Across the Nation." Health Psychology 35 (4): 313-321.
Running head: DISCRIMINATION AND CARDIOVASCULAR DISEASE                               1 
 
The Relationship Between Cumulative Unfair Treatment and Intima Media Thickness and 
Adventitial Diameter: The Moderating Role of Race in  
The Study of Women’s Health Across the Nation 
Laurel M. Peterson, PhDa 
Karen A. Matthews, PhDb,c,e 
Carol A. Derby, PhDd 
Joyce T. Bromberger, PhDb,c 
Rebecca C. Thurston, PhDb,c,e 
aDepartment of Psychology, Bryn Mawr College 
bDepartment of Psychiatry, University of Pittsburgh School of Medicine 
cDepartment of Epidemiology, University of Pittsburgh Graduate School of Public Health  
dDepartment of Epidemiology, Albert Einstein College of Medicine  
eDepartment of Psychology, University of Pittsburgh 
Corresponding Author: Laurel Peterson, PhD; Bryn Mawr College, 101 North Merion Ave, Bryn 
Mawr, PA 19010-2899; 610-526-5012; lmpeterson@brynmawr.edu 
Tables: Table 1.Characteristics of study population (N=1056) 
 Table 2. Race differences on intima media thickness, adventitial diameter, and 
 cumulative unfair treatment  
 Table 3. Relation between cumulative unfair treatment and intima media thickness  
 Table 4. Relation between cumulative unfair treatment and adventitial diameter 
Figures: None 
Running head: Discrimination and subclinical cardiovascular disease  
DISCRIMINATION AND SUBCLINICAL CARDIOVASCULAR DISEASE                          2 
  
Abstract 
Objective: Unfair treatment may have a detrimental effect on cardiovascular health. However, 
little research on chronic health outcomes employs cumulative measures of unfair treatment. We 
tested whether cumulative unfair treatment was associated with greater subclinical 
cardiovascular disease in a diverse sample of African American, Caucasian, Chinese, and 
Hispanic women. We also examined whether this relationship varied by race. Method: The 
Study of Women’s Health Across the Nation is a longitudinal study of midlife women. 
Cumulative unfair treatment was calculated as the average of unfair treatment assessed over 10 
years at 6 time points. Subclinical cardiovascular disease, specifically carotid intima media 
thickness and adventitial diameter, was assessed via carotid ultrasound conducted at study year 
12 in 1056 women. We tested whether cumulative unfair treatment was related to subclinical 
cardiovascular disease via linear regression, controlling for demographic factors including 
socioeconomic status and cardiovascular risk factors.  Results: The relation between unfair 
treatment and subclinical cardiovascular disease significantly varied by race (ps < .05), with 
unfair treatment related to higher intima media thickness (B = .03, SE = .01, p = .009) and 
adventitial diameter (B = .02, SE = .009, p = .013) among Caucasian women only. No significant 
relations between unfair treatment and subclinical cardiovascular disease outcomes were 
observed for African American, Hispanic, and Chinese women. Conclusions: Our findings 
indicate that cumulative unfair treatment is related to worse subclinical cardiovascular disease 
among Caucasian women. These findings add to the growing literature showing that Caucasian 
women’s experience of unfair treatment may have detrimental health implications. Key words: 
unfair treatment, discrimination, socioeconomic status, cardiovascular disease, intima media 
thickness, atherosclerosis, race 
   
DISCRIMINATION AND SUBCLINICAL CARDIOVASCULAR DISEASE                          3 
  
Cardiovascular disease (CVD) is the leading killer of women in the United States, accounting 
for 51% of women’s deaths (Go et al., 2013). Overall, mortality rates for CVD are higher among 
African Americans compared to Caucasians (Gillespie, 2009). The burden of CVD morbidity 
among women varies by race, with prevalence rates of 36.6% among Caucasian women, 48.9% 
among African American women, and 30.7% among Mexican American women (Go et al., 
2013). It is important to understand the key factors, including psychosocial factors, that 
contribute to racial and ethnic cardiovascular health disparities among women. 
A large literature has established that psychosocial stressors contribute to CVD (Everson-
Rose & Lewis, 2005; Steptoe & Kivimäki, 2012), including recent research demonstrating that 
chronic low socioeconomic status (SES) is associated with subclinical CVD (Thurston et al., 
2014). Unfair treatment—which participants have described as inequality, injustice, denial of 
opportunities, being perceived of as incapable or underserving on the basis of one’s identity (e.g., 
race, gender; Williams et al., 2012)—is a particularly relevant psychosocial stressor when 
considering racial and ethnic disparities. A wealth of research has demonstrated that unfair 
treatment is related to negative health outcomes even when accounting for stress and personality 
traits, such as stable negative affect (Pascoe & Smart Richman, 2009; Williams & Mohammed, 
2009; Williams, 2012). African Americans in particular are exposed to race-based unfair 
treatment due to discrimination and socio-historical oppression (Williams & Mohammed, 2009; 
Williams, 2012). Research indicates that African Americans experience higher discrimination 
compared to Caucasians (Borrell et al., 2010; Brown, Matthews, Bromberger, & Chang, 2006; 
Krieger et al., 2011) and other minority groups (Borrell et al., 2010; Brown et al., 2006). Some 
data indicate that among African Americans, discrimination is associated with more pronounced 
cardiovascular stress responses (Clark, 2006; Lepore et al., 2006), blunted nocturnal blood 
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pressure dipping (Beatty & Matthews, 2009; Brondolo et al., 2008; Dolezsar, McGrath, Herzig, 
& Miller, 2014; Ituarte, Kamarck, Thompson, & Bacanu, 1999), and hypertension (Dolezsar et 
al., 2014; Krieger & Sidney, 1996; Sims et al., 2012; c.f., Brown et al., 2006). However, unfair 
treatment may also impact CVD among majority groups and is understudied among racial and 
ethnic minorities other than African Americans (Pascoe & Smart Richman, 2009; Williams & 
Mohammed, 2009; Williams, 2012).  
Discrimination is typically measured using questionnaires administered at a single time point. 
The traditional approaches to assessing unfair treatment are limited in their application to the 
study of chronic disease because they do not capture persistent exposure to unfair treatment. 
Chronic, rather than acute, stressors may be better predictors of the diagnosis and progression of 
chronic health outcomes, particularly for atherosclerosis, which develops over time (Cohen, 
Kessler, & Gordon, 1997; Thurston et al., 2014). Discrimination researchers have called for a 
more comprehensive approach toward discrimination assessment, such as using questionnaires 
administered repeatedly over time, to estimate a cumulative measure of discrimination (Smart 
Richman & Leary, 2009; Stock, Peterson, Gibbons, & Gerrard, 2013; Williams & Mohammed, 
2009). For example, research among African American women demonstrated that cumulative, 
rather than cross-sectional, unfair treatment predicted the presence of coronary artery 
calcification (Lewis et al., 2006).  
CVD develops over the lifespan. Subclinical CVD is detectable prior to clinical events and 
predictive of these events (Bots & Sutton-Tyrrell, 2012; Stein et al., 2008). CVD is associated 
with arterial restructuring, including thickening of the lumen-intima medial (IMT) and widening 
of the media-adventitia, which can be measured noninvasively using ultrasound of the carotid 
arteries. While IMT is more commonly researched than adventitial diameter, both are well-
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validated, reproducible, indicative of vessel remodeling, and predictive of events even among 
low-risk populations (Bots & Sutton-Tyrrell, 2012; Polak et al., 2011; Stein et al., 2008). 
Subclinical CVD measures of atherosclerosis are particularly useful for assessing psychosocial 
influences in racial health disparities because they are subject to less provider bias in detection 
(Bots & Sutton-Tyrrell, 2012; Stein et al., 2008).  
 Racial disparities emerge in IMT prior to adulthood. In a sample of adolescents and young 
adults, African Americans had higher IMT than Caucasians (Kieltyka et al., 2003). Additional 
research has demonstrated these racial disparities in IMT among midlife (Troxel, Matthews, 
Bromberger, & Sutton-Tyrrell, 2003) and older women (Manolio et al., 1995). In research with 
additional ethnic groups, Chinese participants had lower IMT compared to Caucasian, African 
American, and Hispanic participants (Carnethon et al., 2005), and Caucasian participants had 
lower adventitial diameter compared to African American and Chinese participants (Polak et al., 
2011).  
Research has investigated whether unfair treatment is associated with subclinical CVD 
among multiracial samples in the Study of Women’s Health Across the Nation (SWAN), a seven 
site longitudinal study of aging in midlife women. In a subsample of 225 women at the 
Pittsburgh site, reports of unfair treatment were related to IMT cross-sectionally among African 
Americans but not among Caucasians (Troxel et al., 2003). In another subsample of 181 SWAN 
participants (at the two SWAN sites that measured coronary calcification, an indicator of 
calcified plaques in the coronary arteries), African American women who reported cumulative 
unfair treatment assessed at 5 time waves were more likely to have coronary artery calcification; 
this relationship was not apparent among Caucasian women (Lewis et al., 2006).      
   
DISCRIMINATION AND SUBCLINICAL CARDIOVASCULAR DISEASE                          6 
  
Recently six of the seven SWAN sites measured IMT and adventitial diameter and 
accumulated up to six measures of unfair treatment. In consequence, the present study had the 
opportunity to examine the relationship between cumulative unfair treatment and subclinical 
CVD in 1056 older women from a greater variety of racial and ethnic groups than prior SWAN 
reports. Thus, the current research extends the existing literature in several ways. First, we used a 
comprehensive measure of cumulative unfair treatment derived over 10 years. Second, we 
explored the relationship between unfair treatment and subclinical CVD in a multiracial sample, 
which includes Hispanic and Chinese women in addition to African American and Caucasian 
women. We examined these relations while controlling for CVD risk factors as well as key 
demographic factors, such as SES. We predicted higher cumulative unfair treatment would be 
associated with higher IMT and adventitial diameter among the full sample. Second, we 
predicted that race would moderate the relationship between cumulative unfair treatment and 
subclinical CVD outcomes such that the relation between cumulative unfair treatment and 
subclinical CVD would be strongest among African Americans.   
 Method  
Participants 
Data for the present study were drawn from SWAN, an ongoing, multisite, epidemiological 
study of the menopause transition among a racial/ethnically diverse sample of women (see 
Matthews et al., 2009). In 1996-97, middle-aged women were recruited from seven sites across 
the United States. Women were recruited from lists of names or household addresses, and select 
sites supplemented primary sampling frames to obtain adequate numbers of racial/ethnic 
minority women. Seventy-three percent of the women selected were contacted and provided 
information to determine eligibility. Women were eligible at baseline if they were between the 
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ages of 42 and 52, reported having had a menstrual cycle within the last 3 months, had a uterus, 
had at least one ovary, and were not pregnant, lactating, using oral contraceptives or hormone 
therapy. More than half (51%; N = 3302) of eligible women enrolled. SWAN protocols were 
approved by the institutional review boards at each site, and each participant provided written 
informed consent. 
 Women were assessed annually at approximately one year intervals. The present 
investigation examined unfair treatment assessed at baseline (V0) through Visit 10 in relation to 
IMT and adventitial diameter data collected via carotid ultrasound at six sites (Boston, Chicago, 
New Jersey, Pittsburgh, Oakland, Michigan; Visit 12). Of the 1,552 women who underwent 
carotid measurements, data on IMT and adventitial diameter were successfully obtained for 1507 
and 1511 women, respectively. We excluded women with a history of stroke (n = 49), angina (n 
= 73), myocardial infarction (n = 66), or diabetes (n = 288) prior to their carotid scan. An 
additional 131 women were not included in final adjusted models due to other missing data (race 
n = 4; age n = 3; income n = 93; education n = 13; BMI (body mass index) n = 13; diastolic 
blood pressure n = 11; smoking status n = 3; alcohol use n = 13). Compared to women included 
in the analyses, women with missing data were more likely to have higher HOMA (homeostatic 
model assessment) indexes, engage in less physical activity, and have a family income of less 
than $35,000 a year (ps < .05). There were 1,056 women in the final models. 
Measures 
Cumulative unfair treatment and chronic high unfair treatment. Unfair treatment was 
assessed at six time points (Visits 0, 1, 2, 3, 7, and 10) using The Everyday Discrimination Scale 
(Williams, Yu, Jackson, & Anderson, 1997; mean number of time points = 5.52, SD = .95, range 
1 – 6). The Everyday Discrimination Scale is a widely-applied instrument (Williams & 
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Mohammed, 2009), with well-established convergent and divergent validity (Krieger, Smith, 
Naishadham, Hartman, & Barbeau, 2005; Taylor, Kamarck, & Shiffman, 2004). The scale 
includes 10 items assessing the frequency of experiencing unfair treatment in a respondent’s day-
to-day life (e.g., “In your day-to-day life…how often do you receive poorer service than other 
people in restaurants or stores,” 1 = often to 4 = never) and provides options for indicating the 
perceived reasons why unfair treatment occurred (e.g., race, gender). Responses were reverse-
scored so that higher numbers indicated greater unfair treatment. Reliabilities of scale items at 
each time point were high (αs > .88) and responses across items were averaged within time 
points. Reliability of unfair treatment scores across time points was high (α of scores averaged 
across time points = .91) and moderately stable (ICC = .66). Participants’ cumulative unfair 
treatment scores were calculated by averaging their scores across time points (average 
cumulative unfair treatment score, M = 1.66, SD = .44, range 1 - 3.2).  Participants’ experiences 
of chronic high unfair treatment were calculated by summing the number of time points 
participants reported experiencing unfair treatment often or sometimes on any item divided by 
the total number of time points the participants completed the unfair treatment scale. This 
calculation resulted in the percentage (expressed in decimals) of time points participants reported 
experiencing unfair treatment across the study (M = .48, SD = .37, range .00 - 1.00). 
Intima Media Thickness and Adventitial Diameter.  Carotid ultrasound measures and 
readings were conducted at each site using a Terason t3000 Ultrasound System (Teratech Corp, 
Burlington, MA) equipped with a variable frequency 5 to 12 Mhz linear array transducer. 
Technicians were trained by the University of Pittsburgh Ultrasound Research laboratory and 
monitored during the study period for reliability. Technicians took two digitized images of the 
left and right distal common carotid artery. These four images were read using the AMS semi-
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automated edge-detection software (Wendelhag, Gustavsson, Suurküla, Berglund, & Wikstrand, 
1991). Digitized images for readings were obtained from the near and far wall of the left and 
right distal common carotid artery, 1 cm proximal to the carotid bulb. Near and far wall common 
carotid artery IMT measures were obtained by electronically tracing the lumen-intima interface 
and the media-adventitia interface across a 1-cm segment proximal to the carotid bulb. One 
measurement was generated for each pixel over the area resulting in approximately 140 measures 
for each segment. The average values for these measures were recorded for each of the four 
locations, and the mean of the average readings (in mm) at all four locations was used. Common 
carotid artery adventitial diameter was measured at the same four locations as the distance from 
the adventitial-medial interface on the near wall to the medial-adventitial interface on the far wall 
at end-diastole. Readings were completed by readers at the SWAN Ultrasound Reading Center 
(Ultrasound Research Laboratory, Department of Epidemiology, University of Pittsburgh). 
Reproducibility of IMT measures was good to excellent (ICC between sonographers  .77, 
between readers > .90). The scanning and reading protocols have established reliability (Sutton-
Tyrrell et al., 1998) and have been used in numerous studies (e.g., Njoroge, Khoudary, Fried, 
Barinas-Mitchell, & Sutton-Tyrrell, 2011; Sekikawa et al., 2012; Sutton-Tyrrell et al., 2002). 
Covariates. Race/ethnicity was self-identified based on women’s responses to an open-
ended question from the SWAN screening interview, “How would you describe your primary 
racial or ethnic group?” Response classifications were adapted from the NHANES III and coded 
for use as a categorical variable (African American, Caucasian [reference group], Chinese, and 
Hispanic; Centers for Disease Control and Prevention, 1994). Socioeconomic status (SES) was 
assessed using education at baseline (categorized as low: ≤ high school, medium: some college 
or vocational school, high: ≥ college) and total self-report household income at Visit 12 
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(categorized based upon the sample distribution as low: ≤ $34,999, medium: $35,000-$74,999, 
high: ≥ $75,000).  
Participants’ ages and health behaviors were obtained from self-administered questionnaires 
and interviews at Visit 12. Health behaviors included smoking status (past/never, current); 
alcohol use based on weekly servings of beer, wine, liquor, or mixed drinks (categorized as low: 
< once a month, moderate, high: ≥ 2 times a week); and physical activity based on the Kaiser 
Physical Activity Survey, originally adapted from the Baecke physical activity questionnaire 
(Baecke, Burema, & Frijters, 1982; Sternfeld, Ainsworth, & Quesenberry Jr., 1999).  
BMI was calculated (kg/m2) from measured height and weight. Blood pressure was obtained 
from the average of two seated measurements; given the high correlation between systolic and 
diastolic blood pressure (r = .64, p < .0001), only diastolic blood pressure (DBP) was included. 
Analyses also controlled for reported use of medication during the SWAN study, specifically 
medication for lowering blood pressure, medication for lowering lipids, insulin, and 
anticoagulants (considered as separate variables, never versus ever used during the study).  
Phlebotomy was performed in the morning following overnight (min 10-hour) fast within 90 
days of the annual visit. Blood was separated, frozen (-80°C), and sent on dry ice to the 
University of Michigan Pathology Laboratory, CLIA-certified and accredited by the College of 
American Pathologists. Measurements were performed on a Siemens ADVIA 2400 automated 
chemistry analyzer utilizing Siemens ADVIA chemistry system reagents. Glucose was measured 
using a two-step enzymatic reaction utilizing hexokinase and glucose-6-phosphate 
dehydrogenase enzymes. Serum insulin was measured using radioimmunoassay. Insulin 
sensitivity was calculated using HOMA methodology [(fasting insulin*fasting glucose)/22.5] 
(Matthews et al., 1985). Lipid fractions were determined from EDTA-treated plasma. Total 
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cholesterol and triglycerides concentrations were determined by coupled enzymatic methods, 
HDL isolated based upon the method of Izawa et al. (Izawa, Okada, Matsui, & Horita, 1997) and 
LDL was measured directly (Okada, Matsui, Ito, Fujiwara, & Inano, 1998).  
Data Analyses 
IMT, adventitial diameter, triglyceride, and HOMA values were natural log transformed for 
analyses. Baseline differences between included/excluded participants were tested using chi-
squares and independent sample t-tests. Race differences in cumulative unfair treatment and 
IMT/adventitial diameter were examined with general liner models. Associations between 
cumulative unfair treatment and IMT/adventitial diameter were estimated using linear 
regressions. Models were first adjusted for age, race, and site (minimal-adjusted model, Model 
1); second for SES indicators (SES-adjusted model, Model 2);, and third for relevant covariates 
based upon their associations with outcomes at p < .10 (full-adjusted model, Model 3).1 The 
interactions between cumulative unfair treatment [chronic high unfair treatment] and 
race/ethnicity were examined by cross product terms included in all models. Data were cleaned 
in SPSS v20 and analyses were performed in SAS v9.3 using the proc glm command (with class 
statement) for all main empirical analyses.  
Results 
 Women were on average 59 years old at the time of the ultrasound and endorsed an 
average cumulative unfair treatment score of 1.66 (SD = .44; see Table 1). Slightly over half of 
the sample was comprised of non-Hispanic Caucasian women, 26.8% of African American 
women, and the remainder Chinese or Hispanic women. African American and Chinese women 
1 Several psychological covariates considered for Model 3 were not included because they were not significantly associated with 
cardiovascular outcome variables (e.g., depression measured via the Center for Epidemiological Studies Depression Scale 
(Radloff, 1977), anxiety measured via the Generalized Anxiety Disorder-7 scale (Spitzer, Kroenke, Williams, & Löwe, 2006), 
and negative affect measured via the Positive and Negative Affect Scale (Watson, Clark, & Tellegen, 1988); ps > .32). 
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reported significantly higher cumulative unfair treatment than did Caucasian and Hispanic 
women (p < .0001; see Table 2). The most common reported reason for unfair treatment within 
each racial/ethnic group was race/ethnicity for African American (83.4% of the African 
American subsample), Chinese (73.4% of the Chinese subsample), and Hispanic (39.3% of the 
Hispanic subsample) women, and gender for Caucasian (62.2% of the Caucasian subsample) 
women. Caucasian and Chinese women had the lowest IMT while Caucasian and Hispanic 
women had the lowest adventitial diameter (p < .0001; see Table 2). IMT and adventitial 
diameter were correlated with each other (r = .56, p < .0001). 
Cumulative unfair treatment was positively correlated with IMT (r = .096, p = .001) and 
adventitial diameter (r = .12, p = .0001) in bivariate analyses. Unfair treatment was marginally 
associated with IMT in the minimal-adjusted model (Model 1; B = .01, SE = .008, p = .09), 
significantly associated in the SES-adjusted model (Model 2; B = .02, SE = .009, p = .03), but 
was not significant in the full-adjusted model (Model 3; B = .01, SE = .009, p = .20). Similarly, 
unfair treatment was marginally associated with higher adventitial diameter in the minimal-
adjusted model (Model 1; B = .01, SE = .007, p = 06), significantly associated in the SES-
adjusted model (Model 2; B = .02, SE = .007, p = .02), but was no longer significant in the full-
adjusted model (Model 3; B = .007, SE = .007, p = .33).  
 We next examined whether the relation between cumulative unfair treatment and 
subclinical CVD outcomes varied by race/ethnicity. Evidence of a moderating effect of 
race/ethnicity on the relationship between discrimination and subclinical CVD was apparent for 
IMT (cumulative unfair treatment by race interaction, (F(3, 1052) = 2.92, p = .03; Table 3) and 
for adventitial diameter (F(3, 1052) = 2.62, p = .049; Table 4). In models stratified by race, 
higher cumulative unfair treatment was associated with higher IMT among Caucasian women (B 
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= .03, SE = .01, p = .009), but the association between unfair treatment and IMT was not 
significant for African American, Hispanic, and Chinese women (ps > .25). A similar pattern 
emerged for adventitial diameter, as results indicated a significant relationship with cumulative 
unfair treatment among Caucasian women (B = .02, SE = .009, p = .013), but this relationship 
failed to emerge among the other races (ps > .28).   
 Several exploratory analyses were conducted. First, given that we were interested in the 
chronicity of exposure to unfair treatment, we considered the role of chronically high unfair 
treatment in relation to outcomes. Analyses were conducted examining whether high chronicity 
(percentage of times participants rated experiencing high levels of unfair treatment across visits) 
was related to subclinical CVD. No main effect of high chronicity emerged for IMT or 
adventitial diameter (ps > .33), but moderate/significant race by high chronicity interactions 
emerged for IMT (p = .08) and adventitial diameter (p = .02), with follow up analyses 
demonstrating that high chronicity was associated with higher IMT (B = .03, SE = .01, p = .01) 
and adventitial diameter (B = .03, SE = .01, p = .006) among Caucasians, but this relationship 
did not emerge for other races (ps > .24). Second, we were interested in further exploring 
whether cumulative versus single time-point discrimination predicted subclinical CVD. Analyses 
were conducted examining whether discrimination assessed at Visit 10 (the most proximal visit 
to the carotid scan) predicted IMT and adventitial diameter. No main effect of non-cumulative 
discrimination emerged for IMT or adventitial diameter (ps > .46), and race did not moderate the 
relationship between non-cumulative discrimination and IMT/adventitial diameter (ps > .13).  
Discussion 
The present study examined the relationship between cumulative unfair treatment and 
subclinical CVD in a diverse sample of midlife women. The results failed to confirm our first 
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hypothesis; there was no significant relationship between cumulative unfair treatment and IMT 
or adventitial diameter among the aggregate sample when controlling for relevant covariates. 
Our test of the second hypothesis had unexpected results; although the relationship between 
cumulative unfair treatment and subclinical CVD was moderated by race, cumulative unfair 
treatment predicted subclinical CVD among Caucasian rather than the other groups of women. 
Exploratory analyses revealed chronic high exposure to unfair treatment also predicted 
subclinical CVD among Caucasians, but a single time point measure of unfair treatment failed to 
predict subclinical CVD outcomes. These results emerged despite African American and Chinese 
women reporting significantly higher discrimination, and African American women having 
significantly higher IMT and adventitial diameter.  
Cumulative unfair treatment did not predict subclinical CVD for the sample as a whole, and a 
significant relationship failed to emerge among African Americans in race moderation analyses. 
The results of the study are surprising given the wealth of research reporting a relationship 
between perceived discrimination and negative health outcomes (Pascoe & Smart Richman, 
2009; Williams & Mohammed, 2009). However, reviews on cardiovascular outcomes 
specifically suggest that conflicting results may depend on measurement of both the exposure 
(unfair treatment) and the particular CVD outcome of interest (Brondolo, Love, Pencille, 
Schoenthaler, & Ogedegbe, 2011). Null or inverse relationships between discrimination and 
cardiovascular outcomes are reported in the research (e.g., coronary artery calcification; Everage, 
Gjelsvik, McGarvey, Linkletter, & Loucks, 2012 and systolic blood pressure; Ryan, Gee, & 
Laflamme, 2006). Multiple indicators of subclinical CVD are used in research and, while related, 
are far from analogous. Similarly, discrimination can occur across multiple levels that span the 
individual to the institution. Brondolo and colleagues note that a more consistent relationship 
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between interpersonal discrimination and cardiovascular outcomes is reported for ambulatory 
monitoring of blood pressure, perhaps due to capturing a cardiovascular stress response to day-
to-day events. Institutional discrimination (e.g., racial segregation; impoverished environments) 
may be more associated with clinical CVD outcomes (e.g., hypertension diagnosis), and possibly 
via a health behavior pathway (e.g., weight; Brondolo et al., 2011). Research on institutional 
discrimination is an important area for future research. 
The unexpected results may also stem from how discrimination is perceived and reported 
among different groups. Discrimination is commonly conceptualized as an interpretation of the 
social environment, but the construct bears greater complexity. For example, perceptions of 
discrimination could function more as a trait variable, which may stem from response to the early 
social environment. There is a rich discussion in the discrimination literature surrounding the 
perceptions of discrimination, and whether individuals of oppressed groups may be vigilant or 
minimizing when reporting discrimination (Kaiser & Major, 2002). Minimizing the experience 
of discrimination can have negative implications for health outcomes, especially among 
individuals with high internalized racism who report no perceived discrimination (Williams, 
2012). Our study contributes to the literature in that it is a large, diverse, well-characterized 
cohort of women with multiple assessments of discrimination and several well-validated 
subclinical CVD indicators. Future cardiovascular research requires continued discussion 
surrounding the conceptualization and operationalization of unfair treatment.  
Our second hypothesis, that the relationship between cumulative unfair treatment and 
subclinical CVD would be strongest among the African American women, was unsupported. 
Results indicated that race moderated the association between both cumulative and chronicity of 
high unfair treatment and subclinical CVD, but the relationship was significant for Caucasians 
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only. Our findings indicating significant associations among Caucasians but not among African 
Americans are surprising. They add to the growing literature showing that despite reporting less 
unfair treatment, Caucasian women’s experience of unfair treatment has detrimental implications 
for their health (Pascoe & Smart Richman, 2009; Williams & Mohammed, 2009). Caucasian 
women in the sample reported gender as the most common reason for unfair treatment. Notably, 
recent research indicates that experiences of different types of discrimination (e.g., racial, 
gender) are similarly conceptualized as injustice and regardless of the source contribute to stress 
among Caucasians as well as African Americans (Williams et al., 2012). However, women may 
vary in their construal of unfair treatment and subsequent behavioral responses (Smart Richman 
& Leary, 2009). Although speculative, one possibility is that Caucasian women’s less frequent 
experience of unfair treatment, while beneficial, may result in limited opportunities to develop 
effective coping resources (e.g., active, prosocial, group identification). Lack of experience of 
coping with unfair treatment may have particularly deleterious cardiovascular consequences 
among Caucasian women.  
The lack of association observed here between unfair treatment and cardiovascular outcomes 
among African Americans diverges from other findings, suggesting that the relationship between 
unfair treatment and subclinical cardiovascular outcomes is more detrimental for African 
Americans (Beatty & Matthews, 2009; Troxel et al., 2003). One major methodological difference 
between the present study and former research is that both of the former studies assessed unfair 
treatment at one time period rather than cumulatively. However, among African Americans in 
the present study, neither cumulative, high chronicity, nor single time point measurements of 
unfair treatment were significantly associated with subclinical CVD. There may be an 
unmeasured variable, which has greater bearing on African American women’s health than 
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unfair treatment (e.g., racism vigilance; Clark, Benkert, & Flack, 2006). African American 
women in the study reported race as the most common source of unfair treatment, and measuring 
unfair treatment explicitly attributed to racism in the survey questions may have elicited different 
results (Shariff-Marco et al., 2011). Given that the present study includes participants who 
maintained enrollment for over 10 years and were not lost to follow up, an unmeasured variable 
may be related both to maintaining participation in SWAN and resilience to the effects of 
discrimination. The African American women may have developed coping strategies to maintain 
resilience when confronted with unfair treatment and racial discrimination. Future research 
should measure cumulative unfair treatment, subclinical CVD, as well as sources of resilience 
relevant for race-based unfair treatment.   
The study had several limitations. First, subclinical cardiovascular measures were assessed at 
one point in the study, and we cannot conclude that discrimination relates to change in IMT or 
adventitial diameter over time. Future research would benefit from gathering synchronous unfair 
treatment and subclinical cardiovascular data to allow for examination of changes in 
discrimination in relation to changes in cardiovascular outcomes and whether any patterns vary 
by race. Second, the sample included only women and it is unknown if the results would be 
similar among men. Third, Hispanic women made up a small subsample in the dataset, and this 
group was comprised of women of different countries of origin and immigration statuses.  
This study adds to the literature because it is one of the first research studies to investigate 
the relationship between unfair treatment and subclinical CVD among a diverse racial and ethnic 
sample. Additionally, the experience of discrimination was assessed cumulatively over the 
course of 10 years, providing comprehensive assessment of women’s unfair treatment. These 
results suggest that discrimination is related to subclinical cardiovascular health among women 
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but that this relationship functions differently depending on women’s racial/ethnic background. 
Unfair treatment was related to higher IMT and adventitial diameter among Caucasian women 
only, suggesting that Caucasian women’s experience of unfair treatment may have implications 
for their health. These findings suggest the importance of continued investigation as to how and 
why identity-based unfair treatment affects cardiovascular outcomes and highlight the 
importance of the moderating impact of women’s race and ethnic identity on risk factors for 
CVD.  
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Table 1. Characteristics of study population (N = 1056) 
 
Variable Descriptive Indicator 
Cumulative unfair treatment, Mean (SD) 1.66 (.40) 
Age, years, Mean (SD) 59.48 (2.66) 
Study Site, n (%) 
      Michigan 
      Boston, MA 
      Chicago, IL 
      Oakland, CA 
      New Jersey 
      Pittsburgh, PA 
 
186 (17.63%) 
161 (15.25%) 
164 (15.53%) 
258 (24.43%) 
83 (7.86%) 
204 (19.32%) 
Race/ethnicity, n (%) 
   Caucasian  
   African American 
   Chinese 
   Hispanic 
 
580 (54.92%) 
283 (26.8%) 
142 (13.45%) 
51 (4.83%) 
Education, n (%) 
   ≤ High school 
   Some college 
   ≥ College 
 
205 (19.41%) 
324 (30.68%) 
527 (49.91%) 
Income, n (%) 
< $35,000 
$35,000 through < $75,000 
≥ $75,000  
 
217 (20.55%) 
376 (35.61%) 
463 (43.84%) 
BMI, Kg/m2, Mean (SD) 29.09 (6.90) 
DBP, mmHg, Mean (SD) 74.1 (9.95) 
HDL, mg/dL, Mean (SD) 63.9 (16.34) 
LDL, mg/dL, Mean (SD) 123.49 (30.30) 
Triglycerides, mg/dL, Mean (SD) 109.80 (53.78) 
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HOMA index, Mean (SD) 2.61 (2.91) 
Physical activity score, Mean (SD) 7.87 (1.83) 
Current smokers, n (%) 85 (7.86%) 
Alcohol consumption, n (%) 
<1/month 
Moderate 
≥ 2/week 
 
513 (48.58%) 
280 (26.52%) 
263 (24.91%) 
Anticoagulant medication, n (%) 113 (10.7%) 
Cholesterol / lipid lowering medication, n (%) 294 (27.84%) 
Blood pressure medication, n (%) 384 (36.36%) 
Insulin/ pills for sugar, n (%) 12 (1.14%) 
Intima media thickness, mm, Mean (SD) 0.78 (.11) 
Adventitial diameter, mm, Mean (SD) 7.12 (.64) 
Note. All responses derived from Visit 12. Medication use was derived from ever reporting 
medication use over the course of the study. Triglycerides, HOMA, IMT, adventitial diameter all 
natural log transformed for analyses due to non-normality; raw values are reported here
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Table 2. Means and standard deviations of subclinical cardiovascular disease outcomes and unfair treatment by race/ethnicity 
 
 Overall Test Caucasian African American 
 
Chinese Hispanic 
Intima media thickness F(3, 1052)= 19.19,  
p<.0001 
 
.77 (SD = .11)a .82 (SD = .12)b .75 (SD = .11)a c .79 (SD = .11)a b c 
Adventitial diameter F(3, 1052)= 12.17, 
 p<.0001 
 
7.04 (SD = .62)a 7.29 (SD = .68)b 7.17 (SD = .58)a b c 6.94 (SD = .59)a c 
Cumulative unfair 
treatment 
F(3, 1052)= 48.80,  
p<.0001 
 
1.59 (SD =.37) 1.82 (SD = .42)a 1.78 (SD = .38)a 1.24 (SD = .30) 
Note. Subscripts indicate row values which do not significantly differ. Although analyses were conducted with natural log transformed 
IMT and adventitial diameter, raw values are reported here. 
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Table 3. Relation between cumulative unfair treatment and intima media thickness, full sample and models stratified by race 
 
 Full sample 
N= 1056 
Caucasians 
n= 580 
African Americans 
n= 283 
Chinese 
n= 142 
Hispanics 
n= 51 
 F(31, 1024)= 6.77** 
R2= .17 
F(25, 554)= 3.39** 
R2= .15 
F(23, 259)= 1.19 
R2= .10 
F(20, 121)= 2.68** 
R2= .31 
F(20, 30)= 1.60 
R2= .51 
 B (SE) B (SE) B (SE) B (SE) B (SE) 
Discrimination .01 (.009) .03 (.01)** .006 (.02) -.01 (.02) -.07 (.06) 
Race F(3, 1052)= 3.26*     
    African American .03 (.01)**     
    Chinese .01 (.01)     
    Hispanic .01 (.02)     
    Caucasian --     
Discrimination by Race F(3, 1052)= 2.92*     
Note. All models adjusted for site, age, socioeconomic status, BMI, DBP, cholesterol, HOMA, physical activity, smoking, alcohol use, 
and medication use. Numerator degrees of freedom differ between racial groups because the number of sites controlled for varied 
across racial groups, the control variables across all models were identical.  
†p<.1 
*p<.05 
**p<.01 
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Table 4. Relation between cumulative unfair treatment and adventitial diameter, full sample and models stratified by race 
 
 Full sample 
N= 1056 
Caucasians 
n= 580 
African Americans 
n= 283 
Chinese 
n= 142 
Hispanics 
n= 51 
 F(31, 1024)= 6.71** F(25, 554)= 4.82** F(23, 259)= 2.33** F(20, 121)= 1.96* F(20, 30)= 1.51 
 R2= .17 R2= .18 R2= .17 R2= .24 R2= .50 
 B (SE) B (SE) B (SE) B (SE) B (SE) 
Discrimination .007 (.007) .02 (.009)* -.009 (.01) -.006 (.02) -.05 (.04) 
Race F(3, 1052)= 5.35**     
    African American .01 (.007)†     
    Chinese .04 (.01)**     
    Hispanic -.01 (.02)     
    Caucasian --     
Discrimination by Race F(3, 1052)= 2.62*     
Note. All models adjusted for site, age, socioeconomic status, BMI, DBP, cholesterol, HOMA, physical activity, smoking, alcohol use, 
and medication use. Numerator degrees of freedom differ between racial groups because the number of sites controlled for varied 
across racial groups, the control variables across all models were identical. 
†p<.1 
*p<.05 
**p<.01
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